Skip to main content
SpringerLink
Log in

Diabetic Neuropathy

  • Chapter
  • First Online:
The Diabetic Foot

Part of the book series: Contemporary Diabetes ((CDI))

Abstract

Diabetic neuropathy is a common complication of diabetes and a cause of considerable morbidity and increased mortality. Diabetic neuropathy encompasses several neuropathic syndromes, the commonest of which is diabetic peripheral neuropathy (DPN), the main initiating factor for foot ulceration. Some patients with peripheral neuropathy may experience troublesome neuropathic pain that is difficult to treat. DPN is also associated with autonomic neuropathy that can involve almost all the systems of the body and may have devastating consequences such as sudden death. This chapter looks at the common neuropathic complications of diabetes and their treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tesfaye S, Vileikyte L, Rayman G, Sindrup S, Perkins B, Baconja M, Vinik A, Boulton A, on behalf of the Toronto Expert Panel on Diabetic Neuropathy. Painful Diabetic Peripheral Neuropathy: Consensus Recommendations on Diagnosis, Assessment and Management. Diabetes Metab Res Rev. 2011;27:629–38.

    Article  CAS  PubMed  Google Scholar 

  2. Thomas PK. Metabolic neuropathy. J Roy Coll Phys (Lond). 1973;7:154–74.

    CAS  Google Scholar 

  3. Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136–54.

    Article  CAS  PubMed  Google Scholar 

  4. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, Wilson DM, O’Brien PC, Melton LJ. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43:817–24.

    Article  CAS  PubMed  Google Scholar 

  5. Shaw JE, Zimmet PZ. The epidemiology of diabetic neuropathy. Diabetes Reviews. 1999;7:245–52.

    Google Scholar 

  6. Tesfaye S, Stephens L, Stephenson J, Fuller J, Platter ME, Ionescu-Tirgoviste C, The WJD. prevalence of diabetic neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia. 1996;39:1377–84.

    Article  CAS  PubMed  Google Scholar 

  7. Tesfaye S, Chaturvedi N, Eaton SEM, Witte D, Ward JD, Fuller J. Vascular risk factors and diabetic neuropathy. New Engl J Med. 2005;352:341–50.

    Article  CAS  PubMed  Google Scholar 

  8. Watkins PJ, Edmonds ME. Clinical features of diabetic neuropathy. In: Pickup J, Williams G (eds.). Textbook of diabetes vol. 2. Oxford: Blackwell Science, 1997;50.1–50.20.

    Google Scholar 

  9. Andreassen CS, Jakobsen J, Ringgaard S, Ejskjaer N, Andersen H. Accelerated atrophy of lower leg and foot muscles—a follow-up study of long-term diabetic polyneuropathy using magnetic resonance imaging (MRI). Diabetologia. 2009;52(6):1182–91.

    Article  CAS  PubMed  Google Scholar 

  10. Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010 Aug;9(8):807–19.

    Article  PubMed  Google Scholar 

  11. Jensen TS, Gottrup H, Sindrup SH, Bach FW. The clinical picture of neuropathic pain. Eur J Pharmacol. 2001;429:1–3):1-11.

    Article  CAS  PubMed  Google Scholar 

  12. Watkins PJ. Pain and diabetic neuropathy. Br Med J. 1984;288:168–9.

    Article  CAS  Google Scholar 

  13. Tesfaye S, Price D. Therapeutic approaches in diabetic neuropathy and neuropathic pain. In: AJM B, editor. Diabetic Neuropathy. Carnforth: Marius Press; 1997. p. 159–81.

    Google Scholar 

  14. Tesfaye S, Boulton AJ, Dickenson A. Mechanisms and management of diabetic painful distal symmetrical polyneuropathy: bench to bedside. Diabetes Care. 2013;36(9):2456–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. McDermott AM, Toelle TR, Rowbotham DJ, Schaefer CP, Dukes EM. The burden of neuropathic pain: results from a cross-sectional survey. Eur J Pain. 2006;10(2):127–35.

    Article  PubMed  Google Scholar 

  16. Gore M, Brandenburg NA, Hoffman DL, Tai KS, Stacey B. Burden of illness in painful diabetic peripheral neuropathy: the patients’ perspectives. J Pain. 2006;7(12):892–900.

    Article  PubMed  Google Scholar 

  17. Selvarajah D, Cash T, Sankar A, Thomas L, Davies J, Cachia E, Gandhi R, Wilkinson ID, Wilkinson N, Emery CJ, Tesfaye S. The contributors of emotional distress in painful diabetic neuropathy. Diab Vasc Dis Res. 2014;11(4):218–25.

    Article  PubMed  Google Scholar 

  18. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: ten years experience in diabetes. Diabetes Care. 1985;8:491–8.

    Article  CAS  PubMed  Google Scholar 

  19. Boulton AJ, Kirsner RS, Vileikyte L. Clinical practice. Neuropathic diabetic foot ulcers. N Engl J Med. 2004;351(1):48–55.

    Article  CAS  PubMed  Google Scholar 

  20. Ward JD. The diabetic leg. Diabetologia. 1982;22:141–7.

    Article  CAS  PubMed  Google Scholar 

  21. Tesfaye S. Diabetic neuropathy: achieving best practice. Br J Vasc Dis. 2003;3:112–7.

    Article  Google Scholar 

  22. Rajbhandari SM, Jenkins R, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002;45:1085–96.

    Article  CAS  PubMed  Google Scholar 

  23. Ward JD, Simms JM, Knight G, Boulton AJM, Sandler DA. Venous distension in the diabetic neuropathic foot (physical sign of arterio-venous shunting). J Roy Soc Med. 1983;76:1011–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Boulton AJM, Scarpello JHB, Ward JD. Venous oxygenation in the diabetic neuropathic foot: evidence of arterial venous shunting? Diabetologia. 1982;22:6–8.

    Article  CAS  PubMed  Google Scholar 

  25. Edmonds ME, Archer AG, Watkins PJ. Ephedrine: a new treatment for diabetic neuropathic oedema. Lancet. 1983;i:548–51.

    Article  Google Scholar 

  26. Lee JA, Halpern EM, Lovblom LE, Yeung E, Bril V, Perkins BA. Reliability and validity of a point-of-care sural nerve conduction device for identification of diabetic neuropathy. PLoS One. 2014;9(1):e86515.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  27. Selvarajah D, Cash T, Davies J, Sankar A, Rao G, Grieg M, Pallai S, Gandhi R, Wilkinson ID, Tesfaye S. SUDOSCAN: a simple, rapid, and objective method with potential for screening for diabetic peripheral neuropathy. PLoS One. 2015 Oct 12;10(10):e0138224.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. Tavakoli M, Begum P, McLaughlin J, Malik RA. Corneal confocal microscopy for the diagnosis of diabetic autonomic neuropathy. Muscle Nerve. 2015;52(3):363–70.

    Article  PubMed  Google Scholar 

  29. Archer AG, Watkins PJ, Thomas PJ, Sharma AK, Payan J. The natural history of acute painful neuropathy in diabetes mellitus. J Nurol Neorosurg Psychiatr. 1983;46:491–6.

    Article  CAS  Google Scholar 

  30. Ellenberg M. Diabetic neuropathic cachexia. Diabetes. 1974;23:418–23.

    Article  CAS  PubMed  Google Scholar 

  31. Devigili G, Tugnoli V, Penza P, Camozzi F, Lombardi R, Melli G, Broglio L, Granieri E, Lauria G. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain. 2008;131:1912–25.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Tesfaye S, Malik R, Harris N, Jakubowski J, Mody C, Rennie IG, Ward JD. Arteriovenous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia. 1996;39:329–35.

    Article  CAS  PubMed  Google Scholar 

  33. Gibbons CH, Freeman R. Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. Brain. 2015;138:43–52.

    Article  PubMed  Google Scholar 

  34. Said G, Slama G, Selva J. Progressive centripital degeneration of of axons in small-fibre type diabetic polyneuropathy. A clinical and pathological study. Brain. 1983;106:791.

    Article  PubMed  Google Scholar 

  35. Vinik AI, Park TS, Stansberry KB, Pittenger GL. Diabetic neuropathies. Diabetologia. 2000;43:957–73.

    Article  CAS  PubMed  Google Scholar 

  36. Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care. 2001 Aug;24(8):1448–53.

    Article  CAS  PubMed  Google Scholar 

  37. Veves A, Young MJ, Manes C, et al. Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy: a Clinical study. Diabetes Care. 1994;17:1200–2.

    Article  CAS  PubMed  Google Scholar 

  38. Kennedy WR, Wendelschafer-Crabb G, Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology. 1996 Oct;47(4):1042–8.

    Article  CAS  PubMed  Google Scholar 

  39. Ebenezer GJ, Hauer P, Gibbons C, McArthur JC, Polydefkis M. Assessment of epidermal nerve fibers: a new diagnostic and predictive tool for peripheral neuropathies. J Neuropathol Exp Neurol. 2007;66(12):1059–73.

    Article  PubMed  Google Scholar 

  40. Matikainen E, Juntunen J. Diabetic neuropathy: Epidemiological, pathogenetic, and clinical aspects with special emphasis on type 2 diabetes mellitus. Acta Endocrinol Suppl (Copenh). 1984;262:89–94.

    Google Scholar 

  41. Garland H. Diabetic amyotrophy. Br Med J. 1955;2:1287–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Coppack SW, Watkins PJ. The natural history of femoral neuropathy. QJ Med. 1991;79:307–13.

    CAS  Google Scholar 

  43. Casey EB, Harrison MJG. Diabetic amyotrophy: a follow-up study. Br Med J. 1972;1:656.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Bastron JA, Thomas JE. Diabetic polyradiculoneuropathy: clinical and electromyographic findings in 105 patients. Mayo Clin Proc. 1981;56:725–32.

    CAS  PubMed  Google Scholar 

  45. Said G, Goulon-Goeau C, Lacroix C, Moulonguet A. Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann Neurol. 1994;33:559–69.

    Article  Google Scholar 

  46. Laughlin RS, Dyck PJ. Diabetic radiculoplexus neuropathies. Handb Clin Neurol. 2014;126:45–52.

    Article  PubMed  Google Scholar 

  47. Asbury AK, Aldredge H, Hershberg R, Fisher CM. Oculomotor palsy in diabetes mellitus: a clinicopathological study. Brain. 1970;93:555–7.

    Article  CAS  PubMed  Google Scholar 

  48. Zorilla E, Kozak GP. Ophthalmoplegia in diabetes mellitus. Ann Intern Med. 1967;67:968–76.

    Article  Google Scholar 

  49. Goldstein JE, Cogan DG. Diabetic ophthalmoplegia with special reference to the pupil. Arch Ophthalmol. 1960;64:592–600.

    Article  CAS  PubMed  Google Scholar 

  50. Leslie RDG, Ellis C. Clinical course following diabetic ocular palsy. Postgrad Med J. 1978;54:791–2.

    Article  PubMed Central  Google Scholar 

  51. Dreyfuss PM, Hakim S, Adams RD. Diabetic ophthalmoplegia. Arch Neurol Psychiatr. 1957;77:337–49.

    Article  Google Scholar 

  52. Ellenberg M. Diabetic truncal mononeuropathy—a new clincal syndrome. Diabetes Care. 1978;1:10–3.

    Article  CAS  PubMed  Google Scholar 

  53. Boulton AJM, Angus E, Ayyar DR, Weiss R. Diabetic thoracic polyradiculopathy presenting as abdominal swelling. BMJ. 1984;289:798–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Obrosova IG. Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics. 2009;6(4):638–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Malik RA, Newrick PG, Sharma AK, Jennings A, Ah-See AK, Mayhew TM, Jakubowski J, Boulton AJM, Ward JD. Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia. 1989;32:92–102.

    Article  CAS  PubMed  Google Scholar 

  56. Bradley JL, Thomas PK, King RH, Muddle JR, Ward JD, Tesfaye S, Boulton AJM, Tsigos C, Young RJ. Myelinated nerve fibre regeneration in diabetic sensory polyneuropathy: correlation with type of diabetes. Acta Neuropathol-Berl. 1995;90:403–10.

    Article  CAS  PubMed  Google Scholar 

  57. Cameron NE, Eaton SE, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia. 2001;44:1973–88.

    Article  CAS  PubMed  Google Scholar 

  58. Pacher P, Obrosova IG, Mabley JG, Szabó C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem. 2005;12(3):267–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Figueroa-Romero C, Sadidi M, Feldman EL. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord. 2008;9(4):301–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Szabo C. Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction. Br J Pharmacol. 2009;156(5):713–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Obrosova IG, Drel VR, Pacher P, Ilnytska O, Wang ZQ, Stevens MJ, Yorek MA. Ox.idative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes. 2005 Dec;54(12):3435–41.

    Article  CAS  PubMed  Google Scholar 

  62. Fagerberg SE. Studies on the pathogenesis of diabetic neuropathy. II. Relation between clinically demonstrable neuropathy and patho-anatomic investigation of nerve. Acta Med Scand. 1956 Dec 31;156(4):295–302.

    Article  CAS  PubMed  Google Scholar 

  63. Giannini C, Dyck PJ. Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus. Ann Neurol. 1994;36:408–15.

    Article  CAS  PubMed  Google Scholar 

  64. Malik RA, Tesfaye S, Thompson SD, Veves A, Boulton AJM, Ward JD. Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologia. 1993;36:454–9.

    Article  CAS  PubMed  Google Scholar 

  65. Tesfaye S, Harris N, Jakubowski J, et al. Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia. 1993;36:1266–74.

    Article  CAS  PubMed  Google Scholar 

  66. Newrick PG, Wilson AJ, Jakubowski J, Boulton AJM, Ward JD. Sural nerve oxygen tension in diabetes. Br Med J. 1986;193:1053–4.

    Article  Google Scholar 

  67. Tesfaye S, Harris N, Wilson RM, Ward JD. Exercise induced conduction velocity increment: a marker of impaired blood flow in diabetic neuropathy. Diabetologia. 1992;35:155–9.

    Article  CAS  PubMed  Google Scholar 

  68. Young MJ, Veves A, Smith JV, Walker MG, Boulton AJM. Restoring lower limb blood flow improves conduction velocity in diabetic patients. Diabetologia. 1995;38:1051–4.

    Article  CAS  PubMed  Google Scholar 

  69. Reja A, Tesfaye S, Harris ND, Ward JD. Is ACE inhibition with lisinopril helpful in diabetic neuropathy? Diabet Med. 1995;12:307–9.

    Article  CAS  PubMed  Google Scholar 

  70. Malik RA, Williamson S, Abbott CA, Carrington AL, Iqbal J, Schady W, Boulton AJM. Effect of the angiotensin converting enzyme inhibitor trandalopril on human diabetic neuropathy: a randomised controlled trial. Lancet. 1998;352:1978–81.

    Article  CAS  PubMed  Google Scholar 

  71. Witte DR, Tesfaye S, Chaturvedi N, Eaton SEM, Kempler P, Fuller JH, the EURODIAB Prospective Complications Study Group. Risk factors for cardiac autonomic neuropathy in Type 1 diabetes mellitus. Diabetologia. 2005;48:164–71.

    Article  CAS  PubMed  Google Scholar 

  72. Freeman R. Clinical practice. Neurogenic orthostatic hypotension. N Engl J Med. 2008;358(6):615–24.

    Article  CAS  PubMed  Google Scholar 

  73. Horowitz M, Fraser R. Disordered gastric motor function in diabetes mellitus. Diabetologia. 1994;37:543–51.

    Article  CAS  PubMed  Google Scholar 

  74. Lin Z, Forster J, Sarosiek I, McCallum RW. Treatment of diabetic gastroparesis by high-frequency gastric electrical stimulation. Diabetes Care. 2004;27(5):1071–6.

    Article  PubMed  Google Scholar 

  75. Sheehy TW. Diabetic gustatory sweating. Am J Gastroenterol. 1991;86:15–7.

    Google Scholar 

  76. Urman JD, Bobrove AM. Diabetic gustatory sweating successfully treated with topical glycopyrrolate. Arch Intern Med. 1999;159:877–8.

    Article  CAS  PubMed  Google Scholar 

  77. Shaw JE, Abbott CA, Tindle K, et al. A randomized, controlled trial of topical glycopyrrolate, the first specific treatment for diabetic gustatory sweating. Diabetologia. 1997 Mar;40(3):299–301.

    Article  CAS  PubMed  Google Scholar 

  78. Naumann M. Evidence-based medicine: botulinum toxin in focal hyperhidrosis. J Neurol. 2001;248(suppl 1):31–3.

    Article  CAS  PubMed  Google Scholar 

  79. Tesfaye S, Kempler P. Painful diabetic neuropathy. Diabetologia. 2005;48:805–7.

    Article  CAS  PubMed  Google Scholar 

  80. Tesfaye S. Advances in the management of painful diabetic neuropathy. Curr Opin Support Palliat Care. 2009 Jun;3(2):136–43.

    Article  PubMed  Google Scholar 

  81. Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med. 1995;122:561–8.

    Article  Google Scholar 

  82. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003 Jan 30;348(5):383–93.

    Article  PubMed  Google Scholar 

  83. Smith AG, Russell J, Feldman EL, Goldstein J, Peltier A, Smith S, Hamwi J, Pollari D, Bixby B, Howard J, Singleton JR. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care. 2006;29(6):1294–9.

    Article  PubMed  Google Scholar 

  84. Singleton JR, Smith AG, Marcus RL. Exercise as therapy for diabetic and prediabetic neuropathy. Curr Diab Rep. 2015 Dec;15(12):120.

    Article  PubMed  Google Scholar 

  85. Boulton AJM, Drury J, Clarke B, Ward JD. Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care. 1982;5:386–90.

    Article  CAS  PubMed  Google Scholar 

  86. Amitriptyline for neuropathic pain and fibromyalgia in adults. Obtained from www.cochrane.org/CD008242/SYMPT_amitriptyline-for-neuropathic-pain-and-fibromyalgia-in-adults.

  87. Kajdasz DK, Iyengar S, Desaiah D, Backonja MM, Farrar JT, Fishbain DA, Jensen TS, Rowbotham MC, Sang CN, Ziegler D, McQuay HJ. Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicentre, randomised, double-blind, placebo-controlled, parallel-group studies. Clin Ther. 2007;29:536–46.

    Article  CAS  Google Scholar 

  88. Rowbotham MC, Goli V, Kunz NR, Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain. 2004 Aug;110:697–706.

    Article  CAS  PubMed  Google Scholar 

  89. Backonja MM, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E. Gabapentin for symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA. 1998;280:1831–6.

    Article  CAS  PubMed  Google Scholar 

  90. Freeman R, Durso-Decruz E, Emir B. Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomised, controlled trials across a range of doses. Diabetes Care. 2008;31:1448–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Ziegler D, Nowak H, Kempler P, Vargha P, Low PA. Treatment of symptomatic diabetic Polyneuropathy with alpha-lipoic acid: a meta-analysis. Diabet Med. 2004;21:114–21.

    Article  CAS  PubMed  Google Scholar 

  92. Harati Y, Gooch C, Swenson M, Edelman S, Greene D, Raskin P, Donofrio P, Cornblath D, Sachdeo R, Siu CO, Kamin M. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology. 1998 Jun;50(6):1842–6.

    Article  CAS  PubMed  Google Scholar 

  93. Watson CP, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain. 2003 Sep;105(1–2):71–8.

    Article  CAS  PubMed  Google Scholar 

  94. Capsaicin Study Group. The effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Diabetes Care. 1992;15:159–65.

    Article  Google Scholar 

  95. Simpson DM, Robinson-Papp J, Van J, Stoker M, Jacobs H, Snijder RJ, Schregardus DS, Long SK, Lambourg B, Katz N. Capsaicin 8% patch in painful diabetic peripheral neuropathy: a randomized, double-blind, placebo-controlled study. J Pain. 2017;18(1):42–53.

    Article  CAS  PubMed  Google Scholar 

  96. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000909/human_med_001008.jsp&mid=WC0b01ac058001d124.

  97. Vinik AI, Perrot S, Vinik EJ, Pazdera L, Jacobs H, Stoker M, Long SK, Snijder RJ, van der Stoep M, Ortega E, Katz N. Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study. BMC Neurol. 2016;16(1):251.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  98. Anand P, Bley K. Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch. Br J Anaesth. 2011;107(4):490–502.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Kastrup J, et al. Treatment of chronic painful neuropathy with intravenous lidocaine infusion. Br Med J. 1986;292:173.

    Article  CAS  Google Scholar 

  100. Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, Nurmikko T, European Federation of Neurological Societies. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010 Sep;17:1113–e88.

    Article  CAS  PubMed  Google Scholar 

  101. Neuropathic pain in adults: pharmacological management in non-specialist settings Clinical guideline [CG173] https://www.nice.org.uk/guidance/CG173.

  102. Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, Feldman E, Iverson DJ, Perkins B, Russell JW, Zochodne D, American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, American Academy of Physical Medicine and Rehabilitation. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2011;76:1758–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Bansal D, Bhansali A, Hota D, Chakrabarti A, Dutta P. Amitriptyline vs pregabalin in painful diabetic neuropathy: a randomised double-blind clinical trial. Diabet Med. 2009;26:1019–26.

    Article  CAS  PubMed  Google Scholar 

  104. Kaur H, Hota D, Bhansali A, Dutta P, Bansal D, Chakrabarti A. Comparative trial to evaluate amitriptyline and duloxetine in painful diabetic neuropathy: a randomized, double-blind, cross-over clinical trial. Diabetes Care. 2011;34:818–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Quilici S, Chancellor J, Löthgren M, Simon D, Said G, Le TK, Garcia-Cebrian A, Monz B. Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain. BMC Neurol. 2009 Feb 10;9:6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  106. Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet. 2009;374:1252–61.

    Article  CAS  PubMed  Google Scholar 

  107. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005;352:1324–34.

    Article  CAS  PubMed  Google Scholar 

  108. Tesfaye S, Wilhelm S, Lledo A, Schacht A, Tölle T, Bouhassira D, Cruccu G, Skljarevski V, Freynhagen R. Duloxetine and pregabalin: high-dose monotherapy or their combination? The “COMBO-DN study”—a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. Pain. 2013;154(12):2616–25.

    Article  CAS  PubMed  Google Scholar 

  109. Tesfaye S, Watt J, Benbow SJ, Pang KA, Miles J, MacFarlane IA. Electrical spinal cord stimulation for painful diabetic peripheral neuropathy. Lancet. 1996;348(9043):1698–701.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Sheffield, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK

    Solomon Tesfaye MD, FRCP

  2. Department of Endocrinology, Xiangya Hospital, Central South University, Changsha, China

    Jing Wu MD

Authors
  1. Solomon Tesfaye MD, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jing Wu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Solomon Tesfaye MD, FRCP .

Editor information

Editors and Affiliations

  1. Rongxiang Xu, MD, Professor of Surgery, Harvard Medical School Director, The Rongxiang Xu, MD, Center for Regenerative Therapeutics Research Director, Joslin-Beth Israel Deaconess Foot Center Beth Israel Deaconess Medical Center, Boston, MA, USA

    Aristidis Veves

  2. Chief, Division of Podiatry, Beth Israel Deaconess Medical Center, Associate Professor of Surgery, Harvard Medical School, Co-director, Joslin-Bl Deaconess Diabetic Foot Center Consultant, Joslin Diabetes Center, Boston, MA, USA

    John M. Giurini

  3. Associate Professor of Surgery, Harvard Medical School, Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Joslin Diabetes Center, Boston, MA, USA

    Raul J. Guzman

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tesfaye, S., Wu, J. (2018). Diabetic Neuropathy. In: Veves, A., Giurini, J., Guzman, R. (eds) The Diabetic Foot. Contemporary Diabetes. Humana, Cham. https://doi.org/10.1007/978-3-319-89869-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-89869-8_3

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-319-89868-1

  • Online ISBN: 978-3-319-89869-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation